Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2025-12-25 @ 4:54 AM
NCT ID:
NCT02900118
Eligibility Criteria:
Inclusion Criteria:
1. Patient with breast cancer bone metastasis :
* at the initial diagnosis (group 1).
* in a metastatic bone relapse (group 2).
* with a progression of bone metastasis (group 3).
2. Treatment (hormone therapy, chemotherapy) not undertaken (group 1) or prior therapeutic change (group 2 and 3).
3. Patient not opposing the use of its data.
Exclusion Criteria:
1. Claustrophobic patient
2. Patient with an uncontrolled diabetes (fasting glucose \< 1.6 g / l)
3. Patient with a pace-maker or another material incompatible with the MRI 3 Tesla
4. Very algetic patient (Visual Analog Scale (VAS) \> 7)
5. Pregnant or breastfeeding women
6. Patient under 18 or under guardianship
7. Movement disorders (Parkinson disease, etc.) or dementia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02900118
Study Brief:
Protocol Section:
NCT02900118